Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Autoimmune Disorders01:29

Autoimmune Disorders

711
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
711
Acute Pancreatitis II: Clinical Manifestations and Management01:30

Acute Pancreatitis II: Clinical Manifestations and Management

188
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
188
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

133
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
133
Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

184
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
184
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

48
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
48
Gastritis III: Clinical Manifestations and Management01:23

Gastritis III: Clinical Manifestations and Management

544
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
544

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

B cell-derived type I interferon sustains T cell functionality upon strong TCR stimulation during chronic infection.

Immunity·2026
Same author

Letter on 'Altered Pathogen Spectrum of Spontaneous Bacterial Peritonitis in Patients Treated With Proton Pump Inhibitors'. Authors' Reply.

Alimentary pharmacology & therapeutics·2026
Same author

Clinical impact of molecular tumor board inclusion on treatment outcomes in neuroendocrine neoplasms.

Neuroendocrinology·2026
Same author

Robust HLA-B-restricted CD8+ T-cell responses in chronic HBV infection.

JHEP reports : innovation in hepatology·2026
Same author

Determinants of long-term survival from atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma.

European journal of cancer (Oxford, England : 1990)·2026
Same author

Acute and chronic infections drive distinct trajectories in human memory CD4<sup>+</sup> T cell formation.

Immunity·2026

Related Experiment Video

Updated: Sep 27, 2025

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
09:03

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice

Published on: February 3, 2012

19.4K

[Autoimmune Hepatitis - What is important for clinical practice?]

Laura Vogelbacher, Robert Thimme, Tobias Böttler

    Deutsche Medizinische Wochenschrift (1946)
    |April 11, 2022
    PubMed
    Summary

    Autoimmune hepatitis is a chronic liver disease where the body attacks itself. Early diagnosis and immunosuppressive therapy, often lifelong, are crucial for managing this rare condition.

    More Related Videos

    Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms
    11:36

    Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms

    Published on: May 29, 2020

    3.1K
    Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix
    10:37

    Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix

    Published on: October 20, 2021

    3.1K

    Related Experiment Videos

    Last Updated: Sep 27, 2025

    The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
    09:03

    The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice

    Published on: February 3, 2012

    19.4K
    Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms
    11:36

    Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms

    Published on: May 29, 2020

    3.1K
    Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix
    10:37

    Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix

    Published on: October 20, 2021

    3.1K

    Area of Science:

    • Hepatology
    • Immunology
    • Internal Medicine

    Background:

    • Autoimmune hepatitis (AIH) is a rare, chronic liver disease caused by autoimmune processes.
    • Key indicators include elevated liver enzymes, high immunoglobulin levels, specific autoantibodies, and characteristic liver biopsy findings.

    Purpose of the Study:

    • To outline the diagnostic criteria and management strategies for autoimmune hepatitis.
    • To emphasize the importance of early immunosuppressive treatment and long-term patient monitoring.

    Main Methods:

    • Review of diagnostic features: elevated transaminases, hypergammaglobulinemia, autoantibodies, and histology.
    • Assessment of treatment protocols: initiation of immunosuppressive therapy (steroids, azathioprine).
    • Evaluation of long-term management: requirement for lifelong therapy and regular surveillance.

    Main Results:

    • Diagnostic scores aid in identifying AIH.
    • Immunosuppressive therapy achieves remission in most patients.
    • Lifelong treatment is frequently necessary for disease control.

    Conclusions:

    • Prompt diagnosis and initiation of immunosuppressive therapy are vital for managing autoimmune hepatitis.
    • Continuous monitoring, including biochemical tests and imaging, is essential for patients with AIH.